ATE270707T1 - Entepneumovirus und entsprechendes impfstoff - Google Patents

Entepneumovirus und entsprechendes impfstoff

Info

Publication number
ATE270707T1
ATE270707T1 AT00988869T AT00988869T ATE270707T1 AT E270707 T1 ATE270707 T1 AT E270707T1 AT 00988869 T AT00988869 T AT 00988869T AT 00988869 T AT00988869 T AT 00988869T AT E270707 T1 ATE270707 T1 AT E270707T1
Authority
AT
Austria
Prior art keywords
entepneumovirus
corresponding vaccine
avian
vaccine
pneumovirosis
Prior art date
Application number
AT00988869T
Other languages
English (en)
Inventor
Sylvain Gabriel Goutebroze
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE270707T1 publication Critical patent/ATE270707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Loading And Unloading Of Fuel Tanks Or Ships (AREA)
  • Peptides Or Proteins (AREA)
AT00988869T 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff ATE270707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914952A FR2801607B1 (fr) 1999-11-26 1999-11-26 Pneumovirus du canard et vaccins correspondants
PCT/FR2000/003255 WO2001038497A1 (fr) 1999-11-26 2000-11-22 Pneumovirus du canard et vaccins correspondants

Publications (1)

Publication Number Publication Date
ATE270707T1 true ATE270707T1 (de) 2004-07-15

Family

ID=9552613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988869T ATE270707T1 (de) 1999-11-26 2000-11-22 Entepneumovirus und entsprechendes impfstoff

Country Status (6)

Country Link
US (1) US6919084B2 (de)
EP (1) EP1232249B1 (de)
AT (1) ATE270707T1 (de)
DE (1) DE60012042T2 (de)
FR (1) FR2801607B1 (de)
WO (1) WO2001038497A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715922B2 (en) 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
NZ527221A (en) 2001-01-19 2006-09-29 Vironovative B A negative-sense single stranded RNA virus causing respiratory tract illness in susceptible mammals
JP4553588B2 (ja) 2002-02-21 2010-09-29 メディミューン，エルエルシー メタニューモウイルス（ｍｅｔａｐｎｅｕｍｏｖｉｒｕｓ）株と、ワクチン製剤でのおよび抗原配列発現用ベクターとしてのその使用
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
JP2007525178A (ja) 2003-04-25 2007-09-06 メッドイミューン バクシーンズ，インコーポレイティド メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法
JP4976376B2 (ja) * 2005-04-08 2012-07-18 メディミューン，エルエルシー 哺乳動物メタニューモウイルスに対する抗体
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
CN102271704A (zh) 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
CA2757030C (en) 2009-04-03 2019-01-15 Merial Limited Vectors comprising newcastle disease viruses and compositions thereof
RU2592544C2 (ru) 2009-08-21 2016-07-20 Мериал, Инк. Способ получения рекомбинантного вирусного вектора apmv-8
JP5933451B2 (ja) 2009-12-28 2016-06-08 メリアル リミテッド 組換えｎｄｖ抗原及びその使用
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
AU2011224188B2 (en) 2010-03-12 2015-01-22 Boehringer Ingelheim Animal Health USA Inc. Bluetongue virus recombinant vaccines and uses thereof
US8986706B2 (en) 2010-08-31 2015-03-24 Merial, Inc. Newcastle disease virus vectored herpesvirus vaccines
CN102166029A (zh) * 2011-05-05 2011-08-31 陈明科 一种仙草多菌养生精功能饮料
MX361804B (es) 2011-05-27 2018-12-17 Boehringer Ingelheim Animal Health Usa Inc Vacunas genéticas contra el virus hendra y el virus nipah.
HUE033858T2 (en) 2012-02-14 2018-01-29 Merial Inc Rotavirus unit vaccines and method for their preparation and use
EP2861248B1 (de) 2012-06-13 2017-11-15 Merial, Inc. Impfstoffe aus reassortierendem btv und ahsv
JP2016507225A (ja) 2012-12-18 2016-03-10 メリアル インコーポレイテッド Ｉｂｖ、ｃｓｆｖ及びｎｄｖの高解像度融解遺伝子型決定
AU2016282772B2 (en) 2015-06-23 2019-09-05 Boehringer Ingelheim Animal Health USA Inc. PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
MA43016A (fr) 2015-09-29 2018-08-08 Merial Inc Vaccins à particules pseudo-virales (vlp) de parvovirus canin (cpv) et utilisations associées
US10780158B2 (en) 2015-11-16 2020-09-22 Georgia State University Research Foundation, Inc. Tunable vaccine platform against pathogens of the paramyxovirus family
BR112018010494A8 (pt) 2015-11-23 2019-02-26 Merial Inc proteínas de fusão fmdv e e2 e seus usos
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
EP3439690A2 (de) 2016-04-07 2019-02-13 Merial, Inc. Herzwurmimpfstoff, verfahren und verwendungen davon
CN107653231B (zh) * 2017-09-28 2021-02-23 河南科技学院 鸭源性冠状病毒弱毒株ibvdcv35及其应用
CN113384692A (zh) * 2020-12-28 2021-09-14 哈药集团生物疫苗有限公司 鸭呼肠弧病毒、鸭圆环病毒二联灭活疫苗及其制备方法
CN114209821A (zh) * 2021-12-30 2022-03-22 哈药集团生物疫苗有限公司 防治鸭圆环病毒病、新型鸭呼肠孤病毒病和鸭腺病毒病3型的三联灭活疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602791B1 (fr) * 1986-08-18 1988-11-10 Ministere Agri Direction Quali Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
US6605460B1 (en) * 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine

Also Published As

Publication number Publication date
US6919084B2 (en) 2005-07-19
EP1232249B1 (de) 2004-07-07
FR2801607B1 (fr) 2001-12-28
WO2001038497A1 (fr) 2001-05-31
FR2801607A1 (fr) 2001-06-01
DE60012042D1 (de) 2004-08-12
EP1232249A1 (de) 2002-08-21
DE60012042T2 (de) 2005-07-07
US20020192234A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
NO20015073D0 (no) Vaksiner
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
DE60012711D1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
NO20001768L (no) Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
AU2003235707A8 (en) Immunogenic preparations and vaccines on the basis of mrna
UY26555A1 (es) Composición farmacéutica para modulación inmunológica y preparación de vacunas
CY1107457T1 (el) Εμβoλιο κατa του hpv
NL300415I1 (nl) Vaccin tegen antigenen van bacteriën
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
CY1113826T1 (el) Ανοσοενισχυτικα για εμβολια
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
DK1259259T3 (da) Mucosal adjuvansformulering
WO2003051392A3 (en) Streptococcus pneumoniae vaccine
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
WO2003063899A3 (en) Vaccine adjuvant based on a cd4 0 ligand
HUP0500238A2 (hu) Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE274919T1 (de) Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
WO2000061766A3 (en) Telomerase-specific cancer vaccine
WO2001022994A3 (en) Vaccines against neisseria infection
WO2005048918A3 (en) Anthrax vaccine
FR2796282B1 (fr) Vaccin inactive contre la calicivirose feline
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
WO2002070004A3 (en) Papillomavirus vaccines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties